MDG1 — Medigene AG Share News
0.000.00%
Last trade - 00:00- €2.51m
- -€8.97m
- €6.03m
Brief: Medigene: FY Total Revenues At EUR 10.5 Mln
German stocks - Factors to watch on February 22
Brief: Biontech And Medigene Announce Global Collaboration To Advance T Cell Receptor Immunotherapies Against Cancer
Brief: Medigene Announces Global Collaboration With BioNTech To Advance T Cell Receptor Immunotherapies Against Cancer
Brief: Medigene Reports Preliminary Efficacy And Immune Monitoring Data Of Phase I Of Phase I/II Mdg1011 Trial In Blood Cancers
Brief: Medigene Achieves Positive Preliminary Results In Phase I Of Phase I/II Trial Of TCR-T Therapy MDG1011 In Blood Cancers
Brief: Medigene, Iricor, And University Of Montréal Expand Analyses Of Potentially Novel Cancer Antigens
Brief: Medigene Q3 EBITDA Loss Narrows To EUR 6.21 Mln
Brief: Medigene Raises 2021 FY Forecast
Brief: Medigene Says Its PD1-41BB Switch Receptor Improves Tcr-T Cell Functionality
Brief: Medigene Sells Remaining Shares In Immunocore
Brief: Medigene H1 EBITDA Loss Narrows to EUR 4.5 Million
Europe Research Roundup: Adecco Group, Heineken, Pagegroup
Brief: Medigene Q1 EBITDA Loss Narrows At EUR -3.1 Mln
Brief: Medigene Announces Positive Results From Follow-Up Of AML Patients In DC Vaccine Trial
Brief: Medigene Discontinuation Of MDG1021 Development Program
Brief: Medigene Q3 EBITDA Loss Of EUR 5.2 Mln
Brief: Medigene And Cytovant Enter Agreement For DC Vaccine Manufacturing
Brief: Medigene AG Says Expands Patent Protection Of Its Technologies